Renée's leadership extends well beyond operations. While I focus on external-facing initiatives such as content, programs, and strategic vision, she oversees the core business functions of the company, including finance and HR, and is instrumental in driving our growth.
The technology at issue is a subcutaneous cosmetic penile implant, a silicone sleeve placed between the skin and 'Buck's fascia' to enhance girth and length.
Shelton rejects the romanticized notion of invention as unconstrained creativity. He explains that he is not a fan of "blue sky" brainstorming sessions detached from operational constraints. In his view, unconstrained ideation often produces shallow ideas that collapse under real-world scrutiny. Instead, he deliberately over-constrains the problem. Technical constraints. Regulatory constraints. Cost constraints. Operational bottlenecks. Competitive barriers. Existing prior art. All of it goes into the box.
In a recent Tradespace and Above the Law survey, two-thirds of companies that draft patents in-house described IP as a value driver, while 71 percent of companies that outsource drafting viewed IP as a cost. When drafting and prosecution move inside, IP teams work closer to engineers and product leaders. This proximity improves invention quality, strengthens claim strategy, and aligns patent decisions with product direction, market timing, and business priorities.
As the AI revolution accelerates and continues to reshape traditional business models, it has triggered a cascade of new legal, regulatory and policy challenges. At the forefront of these emerging issues are a growing number of high-stakes legal battles between content creators and major Generative AI (GenAI) companies behind large language models (LLMs). This article examines key legal themes and critical questions arising from recent developments at the intersection of AI and Copyright law.
